Urinary IL-8 is a marker of early and long-term graft function after renal transplantation

References

• Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull. 2004;70:71–86.
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004;66:480–485.
   PubMed Web of Science ®Google Scholar
• Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004;66:496–499.
   PubMed Web of Science ®Google Scholar
• Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004;66:486–491.
   PubMed Web of Science ®Google Scholar
• Singbartl K, Ley K. Leukocyte recruitment and acute renal failure. J Mol Med. 2004;82:91–101.
   PubMed Web of Science ®Google Scholar
• Awad AS, Rouse M, Huang L, et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 2009;75:689–698.
   PubMed Web of Science ®Google Scholar
• Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130:41–50.
   PubMed Web of Science ®Google Scholar
• Lipka D, Boratyński J. [Metalloproteinases. Structure and function]. Postepy Hig Med Dosw (Online). 2008;62:328–336.
   PubMedGoogle Scholar
• Schröder JM, Christophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol. 1989;142:244–251.
   PubMed Web of Science ®Google Scholar
• Bauvois B, Mothu N, Nguyen J, et al. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis. Nephrol Dial Transplant. 2007;22:1115–1122.
   PubMed Web of Science ®Google Scholar
• Endo T, Nakabayashi K, Sekiuchi M, et al. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining. Clin Exp Nephrol. 2006;10:253–261.
   PubMedGoogle Scholar
• Stasikowska O, Wągrowska-Danilewicz M. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection. Med Sci Monit. 2007;13:RA31–RA36.
   PubMed Web of Science ®Google Scholar
• Budde K, Waiser J, Ceska M, et al. Interleukin-8 expression in patients after renal transplantation. Am J Kidney Dis. 1997;29:871–880.
   PubMed Web of Science ®Google Scholar
• Matz M, Lorkowski C, Fabritius K, et al. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells. Transpl Immunol. 2016;39:18–24.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Showell HJ, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science. 1989;243:1467–1469.
   PubMed Web of Science ®Google Scholar
• Thornton AJ, Strieter RM, Lindley I, et al. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol. 1990;144:2609–2613.
   PubMed Web of Science ®Google Scholar
• Detmers PA, Lo SK, Olsen-Rgbert R, et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990;171:1155–1162.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Imboden P, Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). Cytokines. 1992;4:1–17.
   PubMedGoogle Scholar
• Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994;56:559–564.
   PubMed Web of Science ®Google Scholar
• Mulligan MS, Jones ML, Bolanowski MA, et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol. 1993;150:5585–5595.
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Williams WW Jr, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97:1056–1063.
   PubMed Web of Science ®Google Scholar
• Hellberg PO, Källskog OT, Ojteg G, et al. Peritubular capillary permeability and intravascular RBC aggregation after ischaemia: effects of neutrophils. Am J Physiol. 1990;258:F1018–F1025.
   PubMedGoogle Scholar
• Klausner JM, Paterson IS, Goldman G, et al. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol. 1989;256:F794–F802.
   PubMedGoogle Scholar
• Mizutani A, Okajima K, Uchiba M, et al. Activated protein C reduces ischaemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood. 2000;95:3781–3787.
   PubMed Web of Science ®Google Scholar
• Kwon O, Molitoris BA, Pescovitz M, et al. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41:1074–1087.
   PubMed Web of Science ®Google Scholar
• Chiao H, Kohda Y, McLeroy P, et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischaemia in mice and rats. J Clin Invest. 1997;99:1165–1172.
   PubMed Web of Science ®Google Scholar
• Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961–973.
   PubMed Web of Science ®Google Scholar
• Venkatachalam MA, Griffin KA, Lan R, et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol. 2010;298:F1078–F1094.
   PubMed Web of Science ®Google Scholar
• Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–350.
   PubMed Web of Science ®Google Scholar
• Ko GJ, Boo CS, Jo SK, et al. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant. 2008;23:842–852.
   PubMed Web of Science ®Google Scholar
• Kim J, Seok YM, Jung KJ, et al. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol. 2009;297:F461–F470.
   PubMed Web of Science ®Google Scholar
• Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997;63:968–974.
   PubMed Web of Science ®Google Scholar
• Yang L, Besschetnova TY, Brooks CR, et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010;16:535–543.
   PubMed Web of Science ®Google Scholar
• Bechtel W, McGoohan S, Zeisberg EM, et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010;16:544–550.
   PubMed Web of Science ®Google Scholar
• Araki M, Fahmy N, Zhou L, et al. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation. 2006;81:783–788.
   PubMed Web of Science ®Google Scholar
• Liu D, Huang P, Li X, et al. Using inflammatory and oxidative biomarkers in urine to predict early acute kidney injury in patients undergoing liver transplantation. Biomarkers. 2014;19:424–429.
   PubMed Web of Science ®Google Scholar
• Liu KD, Altmann C, Smits G, et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care. 2009;13:R104.
   PubMed Web of Science ®Google Scholar
• Borst C, Xia S, Bistrup C, et al. Interleukin-8 transcripts in mononuclear cells determine impaired graft function after kidney transplantation. PLoS One. 2015;10:e0117315.
   PubMed Web of Science ®Google Scholar
• Singh R, Kesarwani P, Ahirwar DK, et al. Interleukin 8–251T > A and Interferon gamma +874A > T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India. Transpl Immunol. 2009;21:13–17.
   PubMed Web of Science ®Google Scholar
• Zhao H, Dong Y, Tian X, et al. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J Nephrol. 2013;2:84–89.
   PubMedGoogle Scholar
• Kwiatkowska E, Domanski L, Bober J, et al. Urinary metalloproteinases-9 and -2 and their inhibitors TIMP-1 and TIMP-2 are markers of early and long-term graft function after renal transplantation. Kidney Blood Press Res. 2016;41:288–297.
   PubMed Web of Science ®Google Scholar
• Turunen AJ, Lindgren L, Salmela KT, et al. Matrix metalloproteinase-9 and graft preservation injury in clinical renal transplantation. Transplant Proc. 2015;47:2831–2835.
   PubMed Web of Science ®Google Scholar
• Mazanowska O, Kamińska D, Krajewska M, et al. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation. Transplant Proc. 2013;45:1458–1461.
   PubMed Web of Science ®Google Scholar
• Mazanowska O, Zabińska M, Kościelska-Kasprzak K, et al. Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients. Transplant Proc. 2014;46:2636–2639.
   PubMed Web of Science ®Google Scholar
• Winn RK, Ramamoorthy C, Vedder NB, et al. Leukocyte-endothelial cell interactions in ischaemia-reperfusion injury. Ann N Y Acad Sci. 1997;832:311–321.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Koga H, Iida M, et al. Blockade of tumor necrosis factor-alpha-converting enzyme improves experimental small intestinal damage by decreasing matrix metalloproteinase-3 production in rats. Scand J Gastroenterol. 2006;41:1320–1329.
   PubMed Web of Science ®Google Scholar